Keyword: Cervarix

GSK

GSK exits U.S. market with its HPV vaccine Cervarix

Facing “very low market demand,” GlaxoSmithKline has decided to pull out of the U.S. market with the HPV vaccine Cervarix. It’s a move that gives Merck a stranglehold on the market as public health officials work feverishly to boost vaccination rates.